# OnCo record inivata (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/inivata/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "inivata" ;
  schema:name "Inivata"@en ;
  schema:description "Inivata was a Cambridge, UK liquid biopsy company whose blood tests find traces of tumour DNA; it was bought by the US laboratory group NeoGenomics in 2021 and its RaDaR test is now sold by NeoGenomics."@en ;
  schema:url <https://onco.cc/companies/inivata/>, <https://neogenomics.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://neogenomics.com/>, <https://ir.neogenomics.com/news-events/press-releases/detail/176/neogenomics-to-acquire-inivata---combining-best-in-class-liquid-biopsy-technology-with-leading-community-oncology-platform>, <https://ir.neogenomics.com/news-events/press-releases/detail/180/neogenomics-completes-inivata-acquisition---combining-best-in-class-liquid-biopsy-technology-with-leading-community-oncology-platform> ;
  schema:addressCountry "GB" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/cgp/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/alk/>, <https://onco.cc/targets/kras/> .
